XML 50 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Summary of Assumptions Used in Black-Scholes Option Pricing Model

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

​

​

Year Ended December 31, 

​

​

    

2022

    

2021

    

2020

 

Risk-free interest rate

 

1.70% - 4.21

%  

0.66% - 1.41

%  

0.35% - 1.57

%

Expected volatility

 

77.7% - 81.9

%  

71.6% - 83.5

%  

71.8% - 74.8

%

Expected dividend yield

 

0

%  

0

%  

0

%

Expected life of employee and Board options (in years)

 

6.25

 

6.25

 

6.25

​

​

Summary of Compensation Expense Relating to Stock Options

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 

​

    

2022

    

2021

    

2020

Research and development

​

$

7,222

​

$

7,126

​

$

6,765

General and administrative

​

 

6,426

​

 

9,569

​

 

4,943

Total stock option expense

​

$

13,648

​

$

16,695

​

$

11,708

Summary of Stock Option Activity

A summary of the Company’s stock option activity related to employees, non-employee members of the Board of Directors and non-employee consultants for the 2019 Plan and the 2014 Plan as of and for the year ended December 31, 2022 is as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

Aggregate

​

​

Number of

​

Average Exercise

​

Intrinsic

​

    

Shares

    

 Price

    

Value

Outstanding, December 31, 2021

 

6,512,280

​

$

15.58

 

​

  

Granted

 

1,899,919

​

 

10.25

 

​

  

Exercised

 

(48,307)

​

 

6.43

 

​

  

Forfeited

 

(356,819)

​

 

14.50

 

​

  

Expired

 

(317,624)

​

 

16.09

 

​

  

Outstanding, December 31, 2022

 

7,689,449

​

$

14.35

​

$

3,028

Weighted average remaining contractual life as of December 31, 2022 (in years)

 

5.95

​

 

  

​

 

  

Options exercisable, December 31, 2022

 

4,972,944

​

$

15.06

​

$

1,940

Weighted average remaining contractual life as of December 31, 2022 (in years)

 

4.40

​

 

  

​

 

  

Options vested and expected to vest as of December 31, 2022

 

7,689,449

​

$

14.35

​

$

3,028

Weighted average remaining contractual life as of December 31, 2022 (in years)

 

5.95

​

 

  

​

 

  

​

Employees And Non-Employee Members Of Board Of Directors [Member]  
Summary of Restricted Stock Unit Activity

A summary of restricted stock unit activity related to employees and non-employee members of the Company’s Board of Directors as of and for the year ended December 31, 2022 is as follows:

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

Number of

​

Average Grant

​

    

Units

    

Date Fair Value

Outstanding, December 31, 2021

 

576,544

​

$

17.50

Awarded

 

474,193

​

 

10.10

Vested and released

 

(268,222)

​

 

16.33

Forfeited

 

(410,002)

​

 

13.62

Outstanding, December 31, 2022

 

372,513

​

$

13.20

Restricted stock units exercisable (vested and deferred), December 31, 2022

 

—

​

​

​

​